Bio-Techne Corporation
Price
FilingsNewest: 8-K, Shareholder voteSep 23 →InsidersNo open-market buys. 1 insider sold $437,187, 0 of 2 sales on a 10b5-1 plan.→HoldersBlackRock 9.0%FMR 8.2%Vanguard 6.5%→PeersClosest companies: DHR, RGEN, LAB→
From the filings
Figures
- Revenue
- $1.22Blast 12 months
- Net income
- $181.9Mlast 12 months
- Operating cash flow
- $292.1Mlast 12 months
- Cash and equivalents
- $264.7Mat the last balance sheet
- Total debt
- $200.0Mat the last balance sheet
- Shares outstanding
- 156.1M shareson issue